Document is current
Any future updates will be listed below
-
Authors
Meiering, Marvin S. https://orcid.org/0000-0002-9747-5015
Weigner, David https://orcid.org/0000-0001-5402-6394
Gärtner, Matti https://orcid.org/0000-0002-1185-1789
Carstens, Luisa
Keicher, Christian https://orcid.org/0000-0002-7552-4082
Luippold, Gerd
Wunder, Andreas
Weigand, Anne
Grimm, Simone
-
Funding
Funding for this research was provided by:
Charité Research Organisation, Berlin, Germany
Boehringer Ingelheim
- License Information
-
More Information
Article History
Received: 5 May 2026
Revised: 27 July 2026
Accepted: 10 August 2026
First Online: 18 August 2026
Ethics
Competing interests: This work was funded by Boehringer Ingelheim Pharma GmbH & Co. KG. Simone Grimm has served as a consultant to and received research support from Boehringer Ingelheim Pharma GmbH & Co. KG. Andreas Wunder was an employee of Boehringer Ingelheim Pharma GmbH & Co. KG. Gerd Luippold is an employee of Boehringer Ingelheim Pharma GmbH & Co. KG. Christian Keicher is an employee of Charité Research Organisation. The authors declare no conflict of interest.
Ethics approval and consent to participate: All methods were performed in accordance with relevant guidelines and regulations. All participants gave written informed consent to participate in the study. The study was approved by the Independent Ethics Committee, Landesamt fϋr Gesundheit und Soziales, and the Federal Institute for Drugs and Medical Devices (BfArM; 4043918). The study is registered at ClinicalTrials.gov (NCT04156035). This research was conducted in accordance with the declaration of Helsinki.
